How were CurAegis Technologies' earnings last quarter?

CurAegis Technologies, Inc. (OTCMKTS:CRGS) posted its quarterly earnings results on Wednesday, May, 13th. The company reported ($0.02) earnings per share for the quarter.

What other stocks do shareholders of CurAegis Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CurAegis Technologies investors own include Allena Pharmaceuticals (ALNA) , Arbutus Biopharma (ABUS) , Matinas BioPharma (MTNB) , Acasti Pharma (ACST) , Aldeyra Therapeutics (ALDX) , Ampliphi Biosciences (APHB) , BIOLASE (BIOL) , Clearside Biomedical (CLSD) and

How do I buy shares of CurAegis Technologies?

Shares of CRGS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:CRGS

CurAegis Technologies (CRGS) Stock Price, News & Analysis

→ Elon Musk’s ChatGPT Could Soon Mint New Millionaires (From InvestorPlace) (Ad)

Free CRGS Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 5,900 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get CurAegis Technologies alerts:

Ad Gold Safe Exchange

Trump’s “Tax Free” Retirement Strategy

Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.

Protect your retirement savings from the inevitable devaluation of the dollar…

About CurAegis Technologies Stock (OTCMKTS:CRGS)

CurAegis Technologies, Inc. does not have significant operations. Previously, it was engaged in the development and marketing of technologies in the areas of wellness, safety, and power. The company was formerly known as Torvec, Inc. and changed its name to CurAegis Technologies, Inc. in June 2016. CurAegis Technologies, Inc. was founded in 1996 and is based in Rochester, New York. On August 4, 2021, an involuntary petition for liquidation under Chapter 7 was filed against CurAegis Technologies, Inc. in the U.S. Bankruptcy Court for the Western District of New York. On August 31, 2021, the involuntary petition was approved by the Court.

Ad Gold Safe Exchange

Trump’s “Tax Free” Retirement Strategy

Protect your retirement savings from the inevitable devaluation of the dollar…

CRGS Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive CRGS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CurAegis Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 5/13/2020
Today: 4/16/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Business Services
Industry: Motor vehicle parts & accessories
Sub-Industry: N/A
Current Symbol: OTCMKTS:CRGS
Previous Symbol: OTCMKTS:TOVC
CUSIP: N/A
CIK: 1063197
Web: www.curaegis.com
Phone: (585) 254-1100
Fax: 585-254-1105
Employees: 7
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

Mr. James R. Donnelly (Age 43)
Pres, CEO, COO & Director
Comp: $175k
Mr. Richard A. Kaplan (Age 76)
Exec. Director
Comp: $65k
Mr. Keith E. Gleasman (Age 75)
Co-Founder & Independent Director
Mr. Jason Burke (Age 48)
Chief Financial Officer
Mr. Richard B. Sullivan
Corp. Counsel
Mr. Brandon Hudson
Head of Product

Key Competitors

View All Competitors

CRGS Stock Analysis - Frequently Asked Questions

How were CurAegis Technologies' earnings last quarter?: CurAegis Technologies, Inc. (OTCMKTS:CRGS) posted its quarterly earnings results on Wednesday, May, 13th. The company reported ($0.02) earnings per share for the quarter.
What other stocks do shareholders of CurAegis Technologies own?: Based on aggregate information from My MarketBeat watchlists, some companies that other CurAegis Technologies investors own include Allena Pharmaceuticals (ALNA), Arbutus Biopharma (ABUS), Matinas BioPharma (MTNB), Acasti Pharma (ACST), Aldeyra Therapeutics (ALDX), Ampliphi Biosciences (APHB), BIOLASE (BIOL), Clearside Biomedical (CLSD) and
How do I buy shares of CurAegis Technologies?: Shares of CRGS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CRGS) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial